Achilles Therapeutics Statistics
Total Valuation
ACHL has a market cap or net worth of $32.20 million. The enterprise value is -$94.72 million.
| Market Cap | 32.20M |
| Enterprise Value | -94.72M |
Important Dates
The last earnings date was Thursday, April 4, 2024, before market open.
| Earnings Date | Apr 4, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ACHL has 41.08 million shares outstanding.
| Shares Outstanding | 41.08M |
| Owned by Insiders (%) | 6.71% |
| Owned by Institutions (%) | 50.86% |
| Float | 21.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.23 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.57, with a Debt / Equity ratio of 0.03.
| Current Ratio | 8.57 |
| Quick Ratio | n/a |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -42.60% and return on invested capital (ROIC) is -51.20%.
| Return on Equity (ROE) | -42.60% |
| Return on Assets (ROA) | -37.50% |
| Return on Capital (ROIC) | -51.20% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$341,495 |
| Employee Count | 204 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ACHL has paid $491,000 in taxes.
| Income Tax | 491,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.66% in the last 52 weeks. The beta is 1.09, so ACHL's price volatility has been similar to the market average.
| Beta (1Y) | 1.09 |
| 52-Week Price Change | -8.66% |
| 50-Day Moving Average | 1.11 |
| 200-Day Moving Average | 0.95 |
| Relative Strength Index (RSI) | 30.46 |
| Average Volume (30 Days) | 793,401 |
Short Selling Information
| Short Interest | 74,834 |
| Short Previous Month | 68,899 |
| Short % of Shares Out | 0.31% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.17 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -75.26M |
| Pretax Income | -69.17M |
| Net Income | -69.67M |
| EBITDA | -64.46M |
| EBIT | -69.17M |
| Earnings Per Share (EPS) | -$1.74 |
Balance Sheet
The company has $131.54 million in cash and $4.62 million in debt, giving a net cash position of $126.92 million or $3.09 per share.
| Cash & Cash Equivalents | 131.54M |
| Total Debt | 4.62M |
| Net Cash | 126.92M |
| Net Cash Per Share | $3.09 |
| Equity / Book Value | 142.37M |
| Book Value Per Share | 3.47 |
| Working Capital | 128.64M |
Cash Flow
In the last 12 months, operating cash flow was -$48.45 million and capital expenditures -$1.10 million, giving a free cash flow of -$49.55 million.
| Operating Cash Flow | -48.45M |
| Capital Expenditures | -1.10M |
| Free Cash Flow | -49.55M |
| FCF Per Share | -$1.24 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ACHL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.13% |
| Shareholder Yield | -2.13% |
| Earnings Yield | -216.35% |
| FCF Yield | -153.87% |
Analyst Forecast
The average price target for ACHL is $2.83, which is 261.06% higher than the current price. The consensus rating is "Hold".
| Price Target | $2.83 |
| Price Target Difference | 261.06% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |